← Browse by Condition
Medical Condition

philadelphia positive acute lymphoblastic leukemia

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT04260022 Phase 1
Recruiting

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

Enrollment
242 pts
Location
United States, Canad...
Sponsor
Ascentage Pharma Group Inc.
View Trial →